Venus Concept Inc. (NASDAQ: VERO) saw an impressive surge in its stock price on Thursday. Initially climbing nearly 7% during regular trading hours, the stock experienced a dramatic 220% increase in the afterhours session, pushing the price to a high of $1.88. For comparison, VERO closed at just $0.47 the previous Friday. This unexpected rise has captured significant attention from investors.
Compliance with Nasdaq Listing Requirements
The remarkable surge in VERO’s stock price can be attributed to the company’s recent announcement of regaining compliance with Nasdaq’s listing requirements. VERO received a notice from Nasdaq confirming that the company met the stockholders’ equity requirement outlined in Nasdaq Listing Rule 5550(b)(1). The compliance followed a $35 million debt-to-equity transaction completed on May 28, 2024.
This transaction helped the company surpass the minimum equity requirement of $2.5 million. Nasdaq had previously issued a deficiency notice on May 31, 2023, but with the successful completion of the debt-to-equity transaction, Venus Concept has secured its listing status and is now under a mandatory panel monitor until June 4, 2025.
New Product License in Canada
In addition to the Nasdaq compliance news, Venus Concept also announced it has received a medical device license from Health Canada for its Venus Versa Pro system. This comprehensive aesthetic platform combines the latest technologies to offer a complete skin rejuvenation experience. It synergizes Intense Pulsed Light (IPL) with SmartPulse™, NanoFractional Radio Frequency with SmartScan™, and Venus Concept’s proprietary (MP)2 technology.
These innovations allow clinicians to provide a variety of procedures aimed at enhancing skin tone, improving tightness, and smoothing texture. Dr. Hemanth Varghese, President and COO of Venus Concept, expressed excitement about the new license, stating, “We are excited to bring to the Canadian market our latest device, the Venus Versa Pro, for practitioners to offer our best-in-class aesthetic technologies.”
Conclusion
VERO’s stock price surge, driven by Nasdaq compliance and new product licensing, has garnered significant investor interest. With its innovative product portfolio and recent strategic achievements, Venus Concept continues to strengthen its position in the global medical aesthetics market. The stock’s extraordinary performance in the afterhours trading highlights the market’s positive reception to the company’s recent milestones.
